CroíValve

Ireland · Healthtech

Develops a transcatheter device to treat tricuspid regurgitation in patients with structural heart disease

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$27MBGF — Role not disclosedEuropean Innovation Council (EIC) — Role not disclosedMedTech Syndicate — Role not disclosed
Sourcescroivalve.com ↗